QRG Capital Management Inc. grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 8.6% in the 3rd quarter, ...

Apple might disrupt the world of consumer tech once again. The US-based tech giant has reportedly developed a secret app that monitors blood sugar. The company is testing two tools to try and ...

Equities researchers at Leerink Partnrs lowered their FY2026 earnings per share (EPS) estimates for DexCom in a research ...

we've narrowed things down to the most popular options on the App Store for Apple Watch, according to user reviews. Here are 12 apps Apple Watch owners have given high praise. Not everybody goes ...

The introduction of sensors like G6 and G7 in international markets also fueled revenue growth. Dexcom anticipates strong growth from its recent product launches and international expansions ...

But with so many apps to choose from ... it can be a pain keeping track of where to go to watch a particular show or movie series. Enter JustWatch, a service that keeps track of the latest ...

In what makes Abbott Laboratories a serious competitor is the much lower price one has to pay for FreeStyle Libre - in comparison to Dexcom's G6 (or G7) and also in comparison to Medtronic's Guardian.

Among its flagship products are the Dexcom G6 and G7 integrated CGM systems, which play an important role in helping individuals monitor their glucose levels effectively. As a prominent player in ...

However, to get the most out of the Ultra, you’ll still have to dig up third-party integrations on the App Stores. That’s where this guide comes in. We’ve picked out five Apple Watch Ultra ...

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other stock picks by Jim Cramer. On Monday, Jim Cramer of Mad Money took a closer look at the market ...

Dexcom Chief Commercial Officer Teri Lawver will leave the company as it grapples with challenges following a sales restructuring. Lawver joined the company in January 2023 for the newly created ...

Shares of Dexcom (NASDAQ:DXCM) were negative Friday after the company released third-quarter results that beat analysts’ expectations but showed a decline in U.S. revenue year over year.